Based on the results, it was hypothesized that YTHDF2 may promote LUSC cell proliferation by activating the AKT/mTOR signaling pathway which is known to play a pivotal role in multiple types of cancer, such as breast cancer and ovarian carcinoma [38, 39]. Here, AKT1 is linked to breast cancer.